HIMS news
Latest 11 stories · newest Oct 23, 2026
Hims & Hers Health reported $753.2M Q2 revenue, up 38% YoY, and raised 2026 full-year guidance to $3.1B-$3.3B. Subscribers reached 2.89M.
Subsidiaries XeCare and Apostrophe finalized a new credit facility with JPMorgan Chase. This financing deal aims to bolster cash flow and working capital.
Hims & Hers Health executed Amendment No. 3 to its revolving credit agreement dated May 29, 2026, with JPMorgan Chase as administrative agent. The multiple amendments within 16 months suggest the company is actively managing its credit facility terms.
Hims & Hers Health entered into an indenture with U.S. Bank Trust Company for convertible senior notes dated May 21, 2026. The offering provides the company with debt financing and conversion equity options for investors.
Hims & Hers plans to issue $300 million of convertible senior notes maturing in 2032, with a $45 million greenshoe option, to fund international expansion including the Eucalyptus acquisition and AI platform investments. The offering provides capital flexibility while the company pursues growth in t…
The same HIMS feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/HIMS/newsSTART FREE